Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 NOV 23 ... and was successfully validated in vivo with microPET imaging of Her2 expression in a xenograft tumor-bearing murine model modulated by. the Hsp90 inhibitor, ...
2009 NOV 23 ... demonstrated an improved therapeutic window compared to CPT or irinotecan in human tumor xenograft studies. The review also reports that XMT-1001, unlike many other conjugated CPT ...
2009 NOV 23 ... were similar to free topotecan and unaffected by gadoCED. In a U87MG intracranial rat xenograft model, a two-dose CED regimen of topoCED co-infused with gadoCED greatly increased ...
2009 NOV 23 ... Three proteins (GDF-15, FGF-19, and VEGF) were also investigated in H358/TetOn/p53 xenograft mice. The ELISA dosage on total tumor protein extracts confirmed the influence of p53 on ...
2009 NOV 23 ... higher cytotoxicity compared to the free form of paclitaxel. In a subcutaneous KB-3-1 xenograft model, HFT-T administration enhanced the specific delivery of paclitaxel into tumor ...
2009 NOV 23 ... effect of methylselenocysteine (MSC) combined with tamoxifen in MCF7 breast cancer xenograft and the underlying mechanisms. MCF-7 breast cancer...
2009 NOV 23 ... Cancer, Prostate-Specific Antigen, Prostatic Neoplasms, Therapy, Treatment, Urology, Xenograft, Xenotransplantion. This article was prepared by Biotech Business Week ...
2009 NOV 23 ... factors mediating tumorigenesis and drug resistance. Using both in vitro and in vivo MM xenograft models, we show that plasmacytoid dendritic cells (pDCs) in the bone marrow (BM) ...
2009 NOV 23 ... p<0.01) and posterior compartment (36% vs 19%, p<0.05) were more frequent in the xenograft group. There were 6 reoperations including secondary laparoscopic sacrocolpopexy (5) and ...
2009 NOV 23 ... when these TICs were grown in vitro under stem cell-promoting conditions. Xenograft tumors of HIF-2 alpha-silenced cells were widely necrotic, poorly vascularized, and ...
2009 NOV 25 ... dynamically image spatiotemporal F-18-Fluorodeoxyglucose (FDG) uptake distributions in xenograft small tumors in dorsal window chambers on mice in vivo," wrote L.Y. Chen and ...
2009 NOV 23 ... 'The effects of vandetanib on paclitaxel tumor distribution and antitumor activity in a xenograft model of human ovarian carcinoma,' new data in ovarian cancer. "This study was ...
2009 NOV 23 ... Neoplasia, Oncology, Pre-Trials Research, Radiation Therapy, Treatment, Women's Health, Xenograft, Xenotransplantion. This article was prepared by Biotech Business Week ...
2009 NOV 23 ... Ovarian Cancer, Ovarian Carcinoma, Pharmaceuticals, Therapy, Treatment, Women's Health, Xenograft, Xenotransplantion, University of Utah. This article was prepared by ...
2009 NOV 16 ... with the ERK inhibitor showed marked in vivo antitumor activity in a human DLBCL xenograft model. Our findings establish a functional molecular interaction between," wrote B.J. ...
